Surgery Today

, Volume 40, Issue 6, pp 561–565 | Cite as

Sudden bilateral sensorineural hearing loss as the presenting symptom of meningeal carcinomatosis of gastric cancer: Report of a case

  • Tetsuro Ohno
  • Yozo Yokoyama
  • Ryuusuke Aihara
  • Erito Mochiki
  • Takayuki Asao
  • Hiroyuki Kuwano
Case Report


Meningeal carcinomatosis is the diffuse infiltration of the meninges by metastatic carcinoma. A 62-year-old man presented with a sudden onset of profound hearing loss affecting both ears. Brain magnetic resonance imaging showed increased signal intensity on T1-weighted images of both vestibulocochlear nerves. Upper gastrointestinal endoscopy revealed a large type 3 gastric cancer, and the pathological diagnosis was poorly differentiated adenocarcinoma. Although combination chemotherapy with oral S-1 and weekly paclitaxel and radiation therapy were performed, the patient’s condition gradually worsened, and he eventually died 12 weeks after the onset of deafness. Isolated bilateral hearing loss is therefore considered to be a rare first manifestation of meningeal carcinomatosis.

Key words

Meningeal carcinomatosis Vestibulocochlear nerves Hearing loss Gastric cancer 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wasserstorm WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors. Experience with 90 patients. Cancer 1982;49:759–772.CrossRefGoogle Scholar
  2. 2.
    Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev 1999;25:103–109.CrossRefPubMedGoogle Scholar
  3. 3.
    Olson ME, Chernik NL, Posner JB. Infiltration of the leptomeninges by systemic cancer: A clinical and pathological study. Arch Neurol 1974;30:122–137.PubMedGoogle Scholar
  4. 4.
    Snyder MC, Heywood BM. Acute bilateral sensorineural hearing loss as the presenting symptom of metastatic lung cancer. Otolaryngol Head Neck Surg 2001;124:592–594.CrossRefPubMedGoogle Scholar
  5. 5.
    Civantos F, Choi YS, Applebaum EL. Meningeal carcinomatosis producing bilateral sudden hearing loss: A case report. Am J Otol 1992;13:369–371.PubMedGoogle Scholar
  6. 6.
    Houck JR, Murphy K. Sudden bilateral profound hearing loss resulting from meningeal carcinomatosis. Otolaryngol Head Neck Surg 1992;106:92–97.PubMedGoogle Scholar
  7. 7.
    Morgan MK, Zammit-Maempel I, Hill J. Meningeal carcinomatosis: An unusual cause of deafness. J R Coll Surg Edinb 1998;43:119–121.PubMedGoogle Scholar
  8. 8.
    Testoni S, Pirodda M, Trossello P, Minguzzi E, Alessandro RD. Meningeal carcinomatosis causing isolated bilateral symmetric progressive hearing loss. Neurol Sci 2005;25:345–347.CrossRefPubMedGoogle Scholar
  9. 9.
    Okamoto Y, Sugiyama H, Yamamoto T. A case of meningeal carcinomatosis presenting with bilateral hearing loss. Brain Nerve 2007;59:1385–1389.PubMedGoogle Scholar
  10. 10.
    Wagemakers M, Verhagen W, Borne B, Venderink D, Wauters C, Strobbe L. Bilateral profound hearing loss due to meningeal carcinomatosis. Clin Neurosci 2005;12:315–318.CrossRefGoogle Scholar
  11. 11.
    Kim L, Glantz M. Neoplastic meningitis. Curr Treat Options Oncol 2001;2:517–527.CrossRefPubMedGoogle Scholar
  12. 12.
    Balm M, Hammack J. Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 1996;53:626–632.PubMedGoogle Scholar
  13. 13.
    Giannone L, Greco FA, Hainsworth JD. Combination intraventricular chemotherapy for meningeal neoplasia. J Clin Oncol 1986;4:68–73.PubMedGoogle Scholar
  14. 14.
    Hitchins RN, Bell DR, Woods RL, Levi JA. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 1987;5:1655–1662.PubMedGoogle Scholar
  15. 15.
    Bleyer WA, Drake JC, Chabner BA. Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med 1973;289:770–773.PubMedCrossRefGoogle Scholar
  16. 16.
    Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008;9:215–221.CrossRefPubMedGoogle Scholar
  17. 17.
    Sunagawa H, Inamine S, Zaha H, Takeshima M, Miyata M. Advanced gastric carcinoma combined with extra-adrenal pheochromocytoma resected after three courses of S-1 and cisplatin as neoadjuvant chemotherapy: report of a case. Surg Today 2008;38:445–448.CrossRefPubMedGoogle Scholar
  18. 18.
    Ohashi M, Kanda T, Hirota M, Kobayashi T, Yajima K, Kosugi S, et al. Gastrojejunostomy as induction treatment for S-1-based chemotherapy in patients with incurable gastric cancer. Surg Today 2008;38:1102–2207.CrossRefPubMedGoogle Scholar
  19. 19.
    Mochiki E, Ohno T, Kamiyama Y, Aihara R, Haga N, Ojima H, et al. Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer. Br J Cancer 2006;95:1642–1647.CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  • Tetsuro Ohno
    • 1
  • Yozo Yokoyama
    • 1
  • Ryuusuke Aihara
    • 1
  • Erito Mochiki
    • 1
  • Takayuki Asao
    • 1
  • Hiroyuki Kuwano
    • 1
  1. 1.Department of General Surgical ScienceGunma University Graduate School of MedicineMaebashiJapan

Personalised recommendations